Transcription of ARTEMETHER AND LUMEFANTRINE TABLETS: Final …
{{id}} {{{paragraph}}}
Document july 2008 ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to the international pharmacopoeia ( july 2008 ) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2007 for addition to the 4th edition of The international pharmacopoeia . Category. Antimalarial. Storage. ARTEMETHER and LUMEFANTRINE tablets should be kept in a well-closed container, protected from light. Additional information. Strength in the current WHO Model list of essential medicines: 20 mg ARTEMETHER and 120 mg LUMEFANTRINE . Strength in the current WHO Model list of essential medicines for children: 20 mg ARTEMETHER and 120 mg LUMEFANTRINE . Requirements Comply with the monograph for Tablets.
Document QAS/07.192/FINAL July 2008 ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications for
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
120 MG DISPERSIBLE TABLETS, 120 MG DISPERSIBLE TABLETS Artemether and lumefantrine, USP Daily Reference Standards Catalog, Integrated Management of Childhood Illness, Recommendations for the treatment and, Patient Information Leaflet QUININE BISULPHATE, Patient Information Leaflet QUININE BISULPHATE 300MG, Medicines and Allied Substances